PCSK9 and Sepsis: Mendelian randomization analysis and experimental validation indicated that in patients with PCSK9 gene mutations, high levels of circulating polyunsaturated fatty acids (PUFAs), particularly ω-3 PUFAs, may reduce susceptibility to sepsis.